Login

Chorus CCO Ed Hyde and Enable CEO Johnathan Eele discuss the latest industry research on AM on Three. 00:10:00

Share On Facebook Share On Twitter

JB has been the CEO of Chorus since 2019.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
President and CEO Peter Delaney of OGE Energy Corp. discusses evaluating new ideas and leveraging expertise to enhance core operations.
00:10:00
Everything about the new bottle of “Tissir Gaz” | Hadj Ali Wakrim, CEO, Afriquia Gaz SAGAZ:CAS
00:10:00
Ford's $3 Billion EV Losses and Jaguar Dealers Trading Franchises for Land Rovers
00:10:00
Simon Bonney on Managing Working Capital and Cash Flow Amidst COVID-19
00:10:00
Testimonial on the Benefits of Using One-to-One IR for Investor Relations
00:10:00
Peter Kaufman of Gordian Group shares his expertise on distressed investment banking and restructuring strategies in an interview with MandA.TV.
00:10:00
Empowering Homeless Communities Through Innovative Housing Solutions
00:10:00
Wilbur Ross on Market Volatility, China's Economic Shifts, and US Interest Rates | Wilbur Ross, Chairman , WL Ross & Co.
00:00:00
Trained as a psychiatrist / David Shumway Jones, Ph.D., M.D. A. Bernard Ackerman Professor of the Culture of Medicine, HMS
00:10:00
Life After the Pandemic: Lessons Learned and Lasting Changes | Nicole Sullivan, co-founder, Prism Planning Partners, LLC.
00:00:00
Anders Hinsby, CEO of Orphazyme
00:10:00
Dr. Martin Enderle, Founder & CEO of Scout24, presents at the NOAH 2012 Conference in San Francisco.

© 2017 - Neuhu+